thesi metronom margin expans consum stapl compani
continu indefinit win retain increment consum requir
rebal back invest growth
redburn import number idea technic view
team
chri start career jp morgan invest manag prior
join redburn work ten year ub first small cap sale
move research softwar final beverag chri read histori
tristan work sabmil almost two decad commerci
strategi role across four contin prior join redburn cover
consum sector deutsch bank hold
manag nijenrod univers netherland bsc
neurobiolog emori univers atlanta
import note see regulatori disclosur page report
combin year step outsid beverag silo look
wide consum stapl sector set framework broader industri
analysi map lead global consum stapl busi public
privat span seven industri categori identifi
compani monitor quarterli global consum tracker fig
univers recov malais organ sale growth
edg back lower half histor trend growth set plateau
level long-run averag
reason legion demograph echo boom post pass
peak increment consum reach coincid sale
slowdown disrupt start-up local omnipres amazon
increas scale speed lack real price often off-set hard-fought
volum mix gain
moder sale growth occur environ ever-expand
margin fig conflict rais profound question sustain
either growth profit choic inform stock select coverag
bifurc separ camp
fig ride wave shore
fig margin go forev
need talk margin
sinc consum stapl industri ground metronom
expans oper margin manufactur extract massiv economi
scale consolid globalis roll-out erp system
consensu extrapol trend go forward circumspect
sustain consum margin thrown spotlight earlier year
reset henkel beiersdorf colgate-palmol inter alia
sinc consum bellweth nestl unilev maintain
import note see regulatori disclosur page report
outlook profit despit reassur balanc growth
profit reach critic junctur manag team need
consid serious whether still achiev medium-term growth ambit
within constraint exist cost structur
competit chang radic start-up longer manufactur
hamper capit constraint product outsourc allow
brand fever-tre juul dollar shave club drunk eleph disrupt
market time would hitherto taken build factori local competit
becom sophist better regul help build consum trust
increment consum africa india set becom expens
acquir sustain packag ingredi need fundament
reconsid market sale undergo transform digit
ad fix cost consum evolv
benchmark cost structur univers look five specif
bucket understand better still ineffici captur
invest could benefici work inform oper profit bridg
countri categori model captur gear volum
conclus especi pertin inflat abil price mix
recov cost inflat central long-term valu creation
underpin fundament prefer beauti distil spirit industri
creat structur margin pressur elsewher
take high road low road
beauti especi skin care offer compel long-term
structur growth driver low penetr emerg market elong price
ladder effici distribut econom market grow organ sale
pa current controversi view howev
bifurc perform loral flourish sinc unilev
henkel lag acceler due disadvantag categori geograph
two iter henkel reset person care margin lower
support relaunch entir haircar portfolio stem organ sale
declin beiersdorf reset divis margin lower acceler
growth current
sinc unilev beauti person divis grow organ
pa limit evid acceler yet compani alreadi
exceed margin target divis spent build
premium beauti portfolio division sale alon expect
import note see regulatori disclosur page report
close gap competitor assum unilev increas rate invest
group level leav us oper margin
consensu within round error target quid pro quo
hit margin target assum group organ sale growth remain pa
lower half compani long-term ambit
consum health slowdown reckitt benckis strike
much past year look compani epitomis consum
stapl model premium sale growth led strong innov pipelin
maintain industry-lead profit capit effici howev growth
came halt result compani reset medium-term
margin expect modest growth stabl
beset anoth round one-off factor momentum yet recov
consensu alreadi move model drop oper margin
regard halfway hous work point specif area specialis
nutrit consum health increas invest could prove fruit
new ceo helm absent major improv underli sale growth
adjust easi compar assum meaning margin
drop put us consensu ebit dramat action could
rebuild investor confid sustain sale recoveri mind
benefit like come beyond
organ sale growth one closest watch metric sector howev
long-stand concern allow compani oper high-but-not-
hyperinflationari market book excess local inflation-l price increas assess
real level organ sale growth calcul annual sales-weight inflat
figur compani base country-level model
adjust surpris see real growth volume-constrain
industri tobacco us beer fig note heineken unilev
strong emerg market footprint deliv littl real
growth volum growth off-set lack real price heineken price
lag lower level unilev acceler volum growth
pa year invest real growth return forecast
modest improv volum growth unilev lack real price
import note see regulatori disclosur page report
fig look real growth
time currenc provid effici correct mechan prevent
compani recognis excess local inflat report result therefor assum
currenc remain continu drag organ growth medium term
consensu extrapol organ rate year three forecast impact
currenc appear drop away rais concern share risk discount
valu local inflat sale growth hard report currenc
restructur baromet health
look profit brought focu billion dollar
spent restructur sinc strip adjust measur
oper profit mani compani cost run pa sale
compani unilev up-front on-going need cost save
given pace disrupt regard restructur necessari recur cost
enterpris remain agil abil grow revenu without yet anoth
major restructur programm good baromet health compani
industri valuat purpos use core measur oper profit includ
restructur cost ensur compar across coverag diageo
other longer adjust cost
differ
compound effect treatment inflat cautiou stanc
margin progress leav us consensu forecast year three ebit ep
major coverag meaning abinbev molson coor
fever-tre imperi brand reckitt benckis fig differ posit
pernod ricard coca-cola european partner ccep beiersdorf
import note see regulatori disclosur page report
fig differ
mind new five-year valuat paradigm establish
averag buoy lower discount rate also help
fundament strong rel estim momentum expand return
discuss consum stapl sector question rather observ
correl bond yield invari come intend make
call bond yield happen present balanc portfolio six buy six
buy reveal prefer busi invest long-term growth
concentr portfolio challeng within industri
upgrad neutral heineken pernod ricard combin stock
offer better valuat support good rel estim momentum britvic coca-
cola european partner bat new buy
sell larg focu compani see downsid medium-term
consensu margin expect reckitt downgrad neutral
downgrad neutral abinbev molson downgrad
neutral growth expect overpr campari fever-tre
anoth busi invest decad industri
like downgrad neutral buy valuat caught
event also launch coverag imperi brand neutral rate
last reiter neutral rate februari
last reiter neutral rate februari
last reiter neutral rate march
last reiter neutral rate april
last reiter buy rate may
import note see regulatori disclosur page report
consum stapl rate valuat summari
note see redburnidea com explan idea wave idea
score estim momentum data correct octob pleas see
www redburnidea com live inform
note consum stapl rel dj world data correct octob
pleas see www redburntoday com/chart live inform
import note see regulatori disclosur page report
attract consum stapl sector mani investor compound
natur growth ever-low interest rate world multipl paid
qualiti growth expand dramat even growth wane
sector broad church map sale mix public privat
consum brand good compani across seven consum
categori aggreg supplier revenu fig includ
relev subsidiari diversifi busi brand food
oper larg meat produc consum health nutrit oper
pharmaceut compani cosmet drink busi luxuri
good compani provid us competit framework
fig map univers
top five supplier other revenu industri us
note tobacco includ revenu china nation tobacco corpor cntc
work identifi multi-national consum stapl compani
track organ sale perform sinc use visibl alpha
consensu expect compani cover
yet map cannabi specif brand consum good categori industri still earli stage
legal develop two main activ compon cannabidiol cbd tetrahydrocannabinol natur occur
much like sugar cocoa hop product mani function cut across consum need smoke vape eaten drunk
rub skin fed dog brand product commercialis yet unclear valu
captur suppli chain preliminari think cannabi ingredi distinct consum categori per se
import note see regulatori disclosur page report
sinc averag organ sale growth pa normal distribut
fig volatil around global
financi crisi even depth downturn univers still deliv
growth herein lie long-term attract compani keep grind
growth long-term holder short-term derat recov
steadi metronom accumul earn dividend
follow recoveri growth slow remain subdu
throughout prospect start recov forecast suggest
moder acceler stabil thereaft still long-
term averag pre-crisi growth formula use start pa top line
sector struggl sustain low end rang
fig adapt new algorithm
redburn compani visibl alpha consensu
compani abinbev unilev proprietari understand
respect market growth channel fragment rise direct-to-
consum tradit method measur market perform
syndic data provid nielsen becom less reliabl moreov
market share gain pyrrhic victori market declin
perform across industri group vari compar averag
organ sale growth normal distribut growth
perform estim fig distil beauti
compani stand highest potenti albeit greater volatil
beauti compani higher exposur china luxuri enjoy strong
acceler momentum distil slower due channel
inventori reduct distort tariff
previou report detail industri these distil brewer soft
drink compani intend repeat work distil
medium-term aspir fall within rang pa organ sale growth
previou work point brewer less structur growth
origin spirit may empti moat januari beyond franchis may
import note see regulatori disclosur page report
volum mix food hpc compani offer modest growth ambit
current run long-term averag target medium-term
growth pa soft drink univers distort earlier stellar growth
monster fever-tre see growth moder
beverag bellweth expect long-term growth pa
despit existenti threat face tobacco recent issu surround
vape us still forecast sustain growth medium term
compani continu transit broader nicotin portfolio total nicotin
consumpt back growth complement popul growth mani
develop market incid smoke rate remain higher
fig spirit beauti
industri specif suppli demand characterist
unit compani sell brand non-dur good vie share
household consumpt expenditur compet durabl good car
televis servic mobil telephon healthcar insur
eat avail household fund detail averag mix
expenditur consum stapl product per capita region fig clearli
demonstr upsid potenti outsid north america western europ
fig content consum basket
expenditur consum stapl us per capita pa
import note see regulatori disclosur page report
popul growth underpin long-term attract consum stock
popul reach billion next year net increas
billion peopl growth pa
high watermark increment new popul peak post-war
baby-boom consumer echo boom sinc
popul get bigger smaller increment consum compani
ride diminish age wave shore
increment movement world popul age cohort
mechan demand model popul per capita consumpt
surpris good correl per capita total
expenditur look top ten countri world-wide popul
matur market us japan lead way fig
cluster china mexico brazil russia per capita
around mark import point consum stapl
product start face increas competit share household expenditur
durabl good also point consum look trade
premium spirit person care product skincar gain greater traction
tip point potenti pass china exampl like
loral pernod ricard seen address univers expand tenfold
million high-net-worth individu million aspir middle-class consum
develop phase volum consum move
formal economi start dispos incom purchas brand
good less time home brew bake
import note see regulatori disclosur page report
fig transit volum valu along curv
per capita consum stapl expenditur vs us pa
standard analysi potenti consum good compani take per-
capita consumpt level develop market assum reach developed-
market level point futur driven econom growth urbanis
evolv social more illustr base case assum consumpt
pattern converg next year two gener
overli simplifi use un popul forecast countri
reach averag expenditur north america western europ would
retail opportun growth pa today price fig
averag global inflat pa unrealist assum long-term
growth consumpt pa
increment consum stapl expenditur us trn compound-annual-growth-rate pa
rest asia
expect next phase expans expens increment
growth increasingli come africa india young grow
import note see regulatori disclosur page report
popul africa countri consum boom us achiev
improv profit driven massiv economi scale africa billion
peopl spread across countri india billion feder union
state territori complex regulatori framework even us european
standard cost per increment consum set increas
opportun also presuppos incumb hemispher compani
captur fair share increment global expenditur today compet
start-up home increasingli sophist better regul local competitor
emerg market threat amazon ever present
price purpos
success brand need purpos need better better owner
better everyon concept purpos address impact brand
consumpt health health societi environ
advertis pay tax due part broader relationship brand
forg potenti come higher oper fiscal cost
mix new price
brand thu driven much emot social need function
requir feed second major forc consum good industri
premiumis core pillar growth combin scienc age
creat barrier entri product differenti allow elong price
ladder categori beauti distil spirit mix improv creat
real long-term valu harder achiev industri
beer food home care mix improv compens lack real price
power protect unit profit rather creat valu state nestl
cfo capit market day year mix new form price
tobacco mix shift next-gener product attract better net price
due current tax structur uncertainti futur cost structur
therefor sustain profit
digit transform consum discov interact purchas consum
brand forc dramat chang compani oper digit strategi
becom far sophist save money put advert
internet build websit encompass everyth suppli chain
sophist come cost unilev diageo loral digit
trailblaz invest signific amount run hundr million
hire digit expert establish digit hub henkel beiersdorf margin
import note see regulatori disclosur page report
reset start year testament cost acceler digit
rise e-commerc
rapid evolut e-commerc direct-to-consum channel chang
shop urbanis alway import driver
brand good mani big brand today born industri revolut
late e-commerc extend distribut market china
reach consum physic retail infrastructur yet reach critic mass
acceler penetr ahead big citi migrat
product high value-to-weight ratio better suit e-commerc
extend reach given econom distribut case scotch anti-ag skin
cream condom make better return case water beer ketchup
analyst attest irresist forc draw forecast toward
mean fade rate growth declin reflect market expect
fig creat opportun consum trend run mani year even
gener compani posit well today product categori
geographi abl sustain out-performance convers turnaround plan
often take longer mani ceo three-year financi model may allow
consum stapl median organ growth normal distribut yoy
valuat framework interest expect sustain
organ sale growth current second forecast year deviat longer
term trend impact exogen polit social regulatori environment
forc moreov growth alreadi embed forward valuat
import note point sale growth may seem like
round error cyclic analyst sustain sever multipl point
valuat differenti compani compound aggreg
forecast averag organ sale growth pa line consensu fig
import note see regulatori disclosur page report
cluster around averag includ consum bellweth nestl
unilev broadli line
top right quarter eye turn buy idea
consensu forecast sustain above-averag sale growth anyth
diagon ahead consensu structur prefer
beauti compani distil therefor direct differ howev
forecast above-consensu growth pernod ricard brown-forman beiersdorf
heineken reveal prefer family-control family-run compani
challeng posit consist invest growth
heineken becom increasingli confid growth strategi
rais medium-term target pa invest brazil south
africa vietnam begin deliv
differ dramat fever-tre compani highest
growth potenti coverag forecast pa
growth us intern offer less off-set rapidli matur uk
market compar consensu expect pa also
consensu abinbev hbc
end scale molson coor face structur barrier growth
us compani coverag without expect growth
also lower growth western europ north america expos cluster
barr britvic ccep henkel tate lyle line
consensu expect tobacco compani
redburn consensu visibl alpha
import note see regulatori disclosur page report
organ sale growth may often first metric referenc result statement
invest thesi consist measur main bugbear
nomin figur compani oper high-but-not-hyperinfl market
therefor book benefit local inflat
assess role inflat play calcul annual sales-weight inflat figur
compani expect compani overweight emerg market
enjoy higher contribut local inflat bat unilev
abinbev worth note nestl above-averag sales-weight
inflat report swiss franc lower inflat therebi increas
differenti report currenc
adjust inflat surpris see real growth tobacco
compani sinc model off-set volum declin price
increas fig molson coor also weak due volum declin us
heineken unilev two compani strong emerging-market footprint
deliv littl real sale growth sinc seen volum
growth off-set price rate inflat heineken price averag
inflat unilev offset volum growth pa
respect expect heineken real sale growth improv volum acceler
pa offset lack real price without signific invest
assum similar step-chang unilev volum prospect therebi
limit real growth potenti embed structur margin pressur
fig assess real growth
argentina recent cast light flaw organ calcul
abinbev campari unilev danon expos compani
move ia hyperinfl account adopt differ method
includ argentina organ growth influenc group report number
import note see regulatori disclosur page report
abinbev still book everyth volum mix local price increas organ
calcul campari captur volum movement unilev origin move
book volum contribut argentina take price increas
part currenc movement sale bridg sinc chang includ
local price increas cap per month pa versu current rate
new methodolog therefor captur local price inflat
organ growth right point becom hyperinflationari ad
unilev previou organ sale growth
time currenc prove effect adjust mechan exampl
unilev sales-weight inflat averag pa ahead
eurozon inflat pa fig annual currenc movement
volatil period averag advers impact sale pa
almost complet erod inflat differ similarli nestl seen
local inflat erod currenc correct uk stock stand brexit
uncertainti devalu sterl thu inflat oversea earn time
polit situat resolv one way anoth
fig tri get money back home
averag sales-weight cpi currenc movement sale pa
market reassuringli effici allow compani book local inflation-l
price increas hard currenc otherwis would built factori
zimbabw book organ growth day day
consensu extrapol organ growth rate year three forecast beyond
impact currenc appear drop away fig
import note see regulatori disclosur page report
redburn currenc impact sale pa vs consensu
differ dramat organ assumpt
compound effect seemingli margin differ coupl currenc
continu off-set excess local inflat rais concern share risk
discount valu local inflation-l sale growth hard report currenc
import note see regulatori disclosur page report
hope ever-expans
hope ever-expans
balanc reliabl compound sale growth constant margin
expans sine qua non invest consum stapl univers
look basket largest global consum stapl compani
around sinc one guis anoth period averag
oper margin doubl consensu
expect look expans fig hiatu
follow global financi crisi sinc margin resum
upward trajectori brief paus
note univers nestl unilev abinbev pro-forma anheuser-busch sabmil bat loral
danon heineken pro-forma kraft food heinz mondelez pro-forma cadburi henkel altria pro-forma
pmi reckitt benckis pro-forma reckitt colman benckis diageo pro-forma guinness/grandmet
chang shape consum revolut inform
technolog old name digit allow autom massiv scale
product rise hand-in-hand sap upgrad cycl
sap roll hana fulli integr in-memori databas platform
encompass previou stand-alone compon erp
call colgate-palmol specif referenc benefit come
upgrad other unilev heineken also
import note see regulatori disclosur page report
hope ever-expans
embark upgrad cycl therefor assum busi usual
anoth phase ever-expand oper margin
benchmark cost structur list multi-national consum stapl
busi assess econom industri fig standardis
possibl cost classif notabl look cost sale exclud
distribut cost distort comparison gross margin across sector
averag margin sector spread beauti
tobacco set tobacco one side distil stand
well peer margin driven attract gross margin good distribut
effici help fund higher market invest still make healthi
beauti compani make attract gross margin reinvest disproportion
level sale market food hpc brew soft drink broadli
around averag
fig wide spread industri econom
consum stapl cost structur industri sale report
sale
colgate-palmol essiti henkel kao reckitt benckis unilev beauti lauder loral
lvmh shiseido distil brown-forman campari diageo pernod ricard mot hennessi rmi cointreau brewer
abinbev asahi carlsberg heineken kirin molson coor royal unibrew soft drink ag barr britvic ccep
cchbc fever-tre monster tobacco altria bat imperi japan tobacco pmi
work allow us assess natur oper leverag sale growth
increment volum price fig compani high gross margin
lower oper margin offer meaning gear revenu growth
assum fix cost element within cost sale assess variabl margin
extra unit volum
mind market sale fix cost budget tend
expand contract sale growth exercis highlight natur
oper gear beauti compani provid natur fund reinvest
import note see regulatori disclosur page report
hope ever-expans
market sale creat virtual circl support higher gross margin
high oper margin dilut leverag distil tobacco compani
fig beauti natur oper leverag
oper profit growth increment volum price
market expenditur often discuss reinvest sale gross
profit provid fund averag gross profit reinvest
market expenditur high gross margin beauti compani spend
sale brand support fig gross margin benefit portfolio mix
improv flow bottom line therebi mitig
theoret benefit come premiumis addit beauti
compani much higher sg cost due number beautician stylist
dermatologist employ recommend promot product cost
worth consid look cost structur implic unilev
rebalanc premium beauti portfolio
fig virtuou circl market invest fund gross margin
consum stapl ex tobacco gross margin vs market net sale
note exclud tobacco analysi due restrict advertis mani market
period consolid globalis allow compani extract major cost
save within consum stapl univers compani
strong track record acquisition-l margin expans exampl
import note see regulatori disclosur page report
hope ever-expans
abinbev stand well above-averag margin expans sinc
diverg consensu expect fig
merger kraft food heinz watch eye capit
warren buffet releas synergi boost pro-forma oper
margin peak compani lack growth organ sale
momentum fade market move away product offer
fund grown short-term profit use reposit
portfolio propos bid unilev success awkward question
cost save ran would avert postpon
case margin rebas lower impair
taken consensu oper margin fall back near pro-forma
pre-merg level sector averag
fig cost save run
note abinbev pro-forma sabmil anheuser-busch pro-forma heinz
compani estim base visibl alpha
abinbev also demonstr import
maintain attract oper profit growth sinc ipo compani follow
clear four-year cycl whitbread/bass ambev anheuser-busch
modelo sabmil case acquir busi saw
three year strong margin expans declin year four enterpris
switch profit never bother market perhap
overlook year four coincid anoth transact
keep flywheel spin abinbev need major acquisit
currenc dividend slower debt repay mean balanc sheet
capac dividend cut sale australian busi asahi
ipo bud asia strengthen balanc sheet absent anoth major deal
given trajectori profit year four deal assum
prudent model margin hiatu abinbev invest reinvigor
margin novemb
import note see regulatori disclosur page report
hope ever-expans
growth south africa protect posit market colombia
continu share gain nigeria
compani pernod ricard loral eschew concept zero-
based-budget zbb prefer invest futur scale rather right-siz
today revenu howev effect permeat think
boardroom diageo carlsberg list goe
prolong period margin expans debat across stapl
sector hitherto heret idea perhap profit push far
expens growth especi context acceler disrupt
start-up increasingli sophist emerg market supplier even amazon
heineken step away previou medium-term margin guidanc
pa growth opportun brazil south africa increasingli
dilut compound capac expans elsewher africa compani felt
constrain public margin target time saw huge potenti
expans post-sabmil industri
henkel receiv lot headlin januari year reset expect
lower compani announc total increment invest
group sale mainli focus consum divis earmark
support plan relaunch entir haircar portfolio innov
offens persil addit acceler digit transform
beiersdorf new ceo stefan de loecker appoint start year
wast littl time rebas margin expect flat
order reinvigor growth part initi includ
increment pa invest consum divis equival
sale
across atlant warn profit growth due higher
level invest support relaunch total toothpast
re-establish commerci growth
given action competitor world largest hpc compani
persist ask result call either directli tangenti whether growth
ambit achiev without reinvest margin compani acknowledg
recent call elev invest requir support retail need
valu improv consum desir innov compani felt
enough product gain balanc top-lin bottom-lin growth
import note see regulatori disclosur page report
hope ever-expans
organ sale momentum slow henkel beiersdorf margin
reset deliv exist growth ambit rather acceler growth per
se competit hpc industri step invest increas
innov margin expect reckitt benckis unilev
thrown sharpli focu
travail us food compani well publicis european
cousin present balanc growth outlook danon guid recur
oper margin consensu
nestl expect underli trade oper margin least
consensu margin expans
expect go togeth mid-single-digit organ revenu growth food
tobacco industri becom someth special situat regulatori
structur next-gener product ngp still larg unknown therefor
tax cost margin structur far settl bat still ambit
pa oper margin expans recent restructur announc
provid necessari fund invest ngp within target
outlook profit imperi brand heavili distort
slower momentum myblu doubt compani ambit achiev
without major margin reset current ceo alison cooper announc
would step appoint successor may prove opportun review
strategi
consum stapl consensu sweet spot pa expans
add sale growth standard stapl growth algorithm
except beiersdorf forecast oper margin expans beyond year one
either line consensu fig
consensu move model declin two compani fever-tre
reckitt benckis differ direct neg
imperi brand molson coor henkel assum flat margin abinbev
consensu still expect margin growth compani bottom
right quarter would differ direct posit
import note see regulatori disclosur page report
hope ever-expans
fig move outsid comfort zone
look detail drive diverg margin
expect bear case fever-tre laid detail earlier
specif focus matur higher margin uk market cost
drive sale lower margin us busi look specif prospect
reckitt benckis unilev beiersdorf molson coor tobacco compani
reckitt benckis reset reinvigor
mani year reckitt benckis epitomis attract consum stapl
model born merger reckitt colman benckis combin
compani deliv consist top-of-class pa sale growth agil
innov lockstep rigor oper cost work capit effici
oper margin doubl peak buoy
success acquisit consum health dilut mead johnson
logic behind pivot household good higher margin consum
health brand sale growth drop stall
judder halt altogeth beset success one-off factor fig
expect bounc help easi compar due
last year suppli problem underli growth still depress
fine balanc act growth margin pass tip point
compani temper market expect medium-term margin growth
full year result februari move modest growth stabl share
respond well day concern could reset
import note see regulatori disclosur page report
hope ever-expans
lower disappoint sale perform thu far consensu move
assum drop oper margin fig view halfway
hous model drop stabl thereaft
fig growth stall
new ceo laxman narasimhan margin reset judici reinvest
liber fund could reinvigor growth avoid one-off becom seen
endem work conclud divis could use extra boost
infant child nutrit ifcn busi could respond well addit
invest sinc acquisit mjn us china absorb lion
share resourc manag time first share lost us previou
manag recov second lost shelf space china need
rebuilt follow last year suppli disrupt suffer lack focu
import market asia latin america under-perform
manag acknowledg need attent
addit note reckitt benckis one big four infant nutrit
busi leverag scienc adult medic nutrit area
offer attract growth like danon reckitt benckis
differenti product nutramigen cow milk allergi
expect innov remain core part infant nutrit strategi recent
launch enfagrow grassf china enfamil neuropro us
perform well compani proven scienc move medical/adult
nutrit could offer addit sourc growth
mjn cost save deliv larg reinvest end
assum increment invest ifcn sale
would still leav oper margin line peer
elsewher reckitt benckis health growth fade face intensifi local
competit durex dettol reckitt benckis local over-the-counter brand
lacklustr period compani need reinvigor momentum
import note see regulatori disclosur page report
hope ever-expans
constrain target stabl margin perhap best durex dettol
huge global potenti
sinc reckitt benckis made first major invest consum health
categori competit landscap evolv still fragment
larger better-focus marketing-savvi competitor glaxosmithklin
gsk doubl scale consum health busi
combin novarti bolster
presenc acquisit merck kgaa consum health busi
gsk consum health expect increas oper margin mid-to-high
would still margin estim reckitt
benckis health make exclud mjn within target gsk expect reinvest
synergi equival pa sale support
innov acceler growth base increment invest gsk
plan assum reckitt benckis spend increment
equival sale look
consensu margin drop forecast
final hygien divis unilev seen strong recent
momentum henkel reset margin lower reckitt benckis benchmark
profit home care oper margin compar peer group
averag help product geograph mix finish wick
strong brand develop market focu acceler global roll
would increment growth assum invest
hygien equival anoth division sale
total model increment invest sale
broadli keep margin reset sector put us
consensu oper profit assum immedi
acceler sale growth invest would give us greater confid
reckitt benckis trace path back long-term object pa organ
unilev margin connect growth
unilev also chart similar less dramat slowdown organ sale growth
sinc expect bottom half long-term target pa
fig consensu expect sequenti slowdown due
tougher compar pick margin
reckitt benckis debat centr around balanc pubic sale
growth margin target manag hand forc
knock door earli prompt acceler exist connect
growth programm deliv cost save three year
issuanc underli oper profit margin
import note see regulatori disclosur page report
hope ever-expans
manag stuck target new ceo alan jope
consist nuanc state prioriti qualiti growth confirm
encompass unlik reckitt benckis market move
build margin reset unilev consensu expect
continu modest expans thereaft fig
low-end rang assum stabl margin
oper margin repres third step-chang unilev profit
year move earli
period margin expans period consolid
assum pattern repeat
fig slowdown pa
sever move part unilev margin outlook one shift
sale mix higher margin beauti person busi turn
compani look shift beauti portfolio toward skincar luxuri
spent across eight transact built sale premium busi
equival divis given scale yet driven discern
improv growth moreov unilev lag acceler beauti
market sinc hamper exposur us haircar fig
unilev alreadi exceed oper margin target beauti divis
ahead peer fig henkel seen growth stall
exacerb destock china invest increment
relaunch entir haircar portfolio given competit pressur us
assum increment invest unilev would prudent ensur
deliv sustain growth especi look cost structur loral
lauder make lower margin assum contract
beauti divis oper margin
import note see regulatori disclosur page report
hope ever-expans
beauti organ sale growth vs market yoy pa
note dot line market averag growth period
fig henkel reset unilev reinvest
note ensur compar alloc central cost henkel
redburn compani visibl alpha consensu lauder
beiersdorf natur leverag reset
new ceo stefan de loecker appear renew dynam
compani reset margin expect portfolio respond
increment suppli chain sale distribut invest made asia
latin america consid strength skincar beiersdorf
bigger china current weigh haircar brand
nivea la prairi eucerin consum divis sale
expos prevail skincar trend current favour earli
success india given compani confid expand aggress
geograph clear triumvir brand cover mass consum nivea
activ cosmet eucerin luxuri anti-ag la prairi
nivea grown organ pa sinc slow pa sinc fig
achiev without broad global sale network
competitor remind us conserv consid consist expans
daniel whiskey aegi brown-forman allow compani
sustain pa growth decad
eucerin display similar growth trend la prairi shift sever
gear recent grow strongli across travel retail asia north america
attract gross margin invest beiersdorf see consum
divis sale acceler mid-point medium-term ambit
pa turn pull natur oper leverag oper
margin forecast hit mid-point compani guidanc
ahead consensu fig
import note see regulatori disclosur page report
hope ever-expans
beiersdorf sale lead brand bn
fig beiersdorf hit margin target
note sale constant currenc adjust chang account
molson coor share margin donor
move person care beer molson coor find oper profit
beholden us main purveyor discount per iri
data past decad averag price case beer us increas
molson coor us subsidiari millercoor kept pace
averag price per case portfolio sell greater
discount market averag
acceler volum declin millercoor depend lower price
segment fig new mainstream american beer sit sweet spot
case occupi brand michelob ultra corona modelo
much like tito vodka attract unisex emot social benefit attribut
beer access price point supersed proposit offer
cheaper male centric beer father
import note see regulatori disclosur page report
hope ever-expans
miller coor brand price /case sale growth yoy
yoy sale growth septemb
millercoor belatedli discov jewel portfolio refus
back joint ventur sabmil peroni import final get
focu though concern current market campaign lose
intrins design cue inher brand success
greater concern recent innov reactiv distributor need rather
base consum insight
behaviour supposedli fast follow reminisc similar action
like alli domecq scottish newcastl imperi tobacco strategi
proven fail even though distributor may want michelob ultra fighter
consum seek weaker copi compani one point led
develop beer categori introduct aluminium can miller
rather sad indict
molson coor weak us reflect volum market share
loss sinc peak combin entiti miller coor lost
market share fig acceler last decad averag
share loss pa recent action give us confid current trend
revert fig end next decad expect millercoor back
level market share phillip morri acquir
miller busi introduc miller
disclosur inher bia due histor involv manag birra peroni busi itali
import note see regulatori disclosur page report
hope ever-expans
fig back
despit strong end summer recent data see acceler market
share loss give us confid problem structur lie
heart portfolio remedi new hot innov
persist market share loss continu sale declin present constant pressur
margin continu absorb hard-earn cost save henc compani
recognit cost associ next effici programm
treat except
fig cycl margin eros
nicotin transit
fundament attract tobacco investor profit reliabl cash
across peer group fig
gross margin attract advertis market restrict reduc cost
brand support keep barrier entri combust tobacco high
import note see regulatori disclosur page report
hope ever-expans
fig profit come standard
tobacco cost structur sale report
sale
fundament littl attract late existenti concern
weigh upon sector reflect derat past year
sinc break-up american tobacco compani sector
continu face met existenti threat surgeon gener report
subsequ market restrict cigarett paper master settlement
agreement moment suppos death knell
industri chagrin oppon tobacco invest option thrive
rather die
regul rule govern tobacco us allevi current
concern particularli propos ban menthol cigarett restrict next-
gener nicotin deliveri system propos menthol ban unlik
enact end ten-year medium-term forecast regulatori path
favour process expedi lack coher regulatori framework open
window disruptor vape led juul potenti life-threaten thc-
infus altern classifi epidem fda propos
restrict complic path approv like favour patient
well-financ current incumb tobacco sector
perhap time differ current valuat tobacco
manufactur certainli reflect sentiment nevertheless world
adult popul continu smoke still close billion consum
serv look top market bat specif estim
address number consum remark stabl north
million smoker sinc fig declin incid rate develop market
off-set popul growth consumpt market pakistan
bangladesh indonesia
import note see regulatori disclosur page report
hope ever-expans
note total adult smoker top bat market plu new net next-gener nicotin user smoke exclud china
even develop market seen increas nicotin usag new deliveri
system replac smoke though convers smoker remain core focu
tobacco compani past five year million net new nicotin user appear
enter categori use next-gener product never
current smoke
thu far year us seen rate declin combust cigarett
acceler ad invest behind vuse/vyp bat myblu imb
recent approv iqo altria tobacco compani seek counteract declin
gain fair share switcher new nicotin user
plan thu far work imperi brand last month issu
profit warn follow announc ceo would exit busi
fda cite vape epidem amongst youth regulatori fear
accord compani inhibit retail fulli execut market
programm behind myblu increment sale imperi next-gener product
stall regard imperi woe company-specif especi given bet
vape although bat enjoy better momentum across diversifi
portfolio next-gener technolog regulatori environ continu
put pressur valuat tobacco compani
import note see regulatori disclosur page report
hope ever-expans
fig bat sustain growth premium
look bat two prism underli abil maintain
tradit tobacco algorithm price increas obscur excis offset
manag volum declin abil compet potenti win
though us account bat revenu compani continu
favour expos emerg market volum declin degener slower
rate fig expect growth rate market off-set concern
fig growth engin built around us
bat sale ebit margin post currenc sale compound-annual-growth-rate countri vs averag
whatev regulatori outcom vape next-gener product
us beyond see bat well posit take advantag wherea rise
juul caught tobacco compani guard bat initi like
import note see regulatori disclosur page report
hope ever-expans
surviv increasingli appear equal rapid demis juul
practic new sustain categori take time build
bat dedic year next-gener initi
expand full realm possibl includ vape tobacco-h product
modern oral altern recent announc reorganis see
role elimin give bat firepow compani structur
acceler necessari transform expect level invest
save reinvest organis eventu align innov faster
categori depend technolog design scale addict
imperi brand recent profit warn highlight expos geographi fig
lack invest requir next-gener product despit
compani optic attract valuat expect next ceo take
opportun review direct acceler dispos programm
fig weigh europ
imperi brand sale ebit margin post-curr sale compound-annual-growth-rate countri
chang like involv heighten cost whether increas
invest next-gener product restructur cost potenti
dilut scale dispos also expect compani final clean
report structur current includ one-off benefit profit
dispos adjust oper profit
import note see regulatori disclosur page report
hope ever-expans
summari assum bat grow sale maintain modest margin-
expans trajectori fig problem face imperi deep-
seat requir invest remedi fig
fig fall empir
baromet disrupt
face constant acceler disrupt need restructur oper
suppli chain distribut market support function free fund
improv agil on-going imper enterpris remain competit
case reflect previou period underinvest therebi inflat
histor profit take hit current year
organ sale growth definit non-gaap underli adjust
oper profit vari dramat princip distort treatment
restructur charg except item
across coverag combin total oper
 a-rel restructur cost treat except averag sale pa
fig consist risen sinc pace disrupt increas
restructur cost treat except
import note see regulatori disclosur page report
hope ever-expans
treat restructur cost except alway thorni issu
case charg relat captur synergi acquisit merger
one-off natur fig inflat abinbev acquisit cycl
compani constant integr mode often hard disentangl cost
relat genuin synergi on-going restructur
compani highest averag level restructur histor
tend disrupt chang market tobacco
compani need adjust cost base year adapt declin combust
tobacco sale pivot next-gener product
restructur proven constant rather except cost
industri diageo move report oper profit adjust restructur
treat on-going strike despit engag
major product programm oper margin absorb cost
without step profit fig
compani up-front expect on-going restructur cost
decad restructur unilev move core oper profit rebas
margin lower restructur cost longer treat except fig
due scale programm unilev move back underli
measur oper profit exclud restructur cost compani
last year programm howev result call ceo
acknowledg need continu effici perpetu everi
year assum annual recur restructur charg sale pa
fig unilev
view restructur real oper cost enterpris abil grow
sale less increment restructur import baromet health
ensur compar valuat like diageo use core measur
oper profit ep exclud except item includ restructur
import note see regulatori disclosur page report
hope ever-expans
averag restructur cost treat except sale
import note see regulatori disclosur page report
univers broke psycholog forward price-to-earnings ceil
sinc establish new trade rang low end normal distribut
past five year dovetail top end past year
modest derat sinc peak juli median forward price-to-earnings
coverag fig premium averag
premium averag past five year
sinc qualiti growth stock consum stapl group rerat
establish new trade rang growth expect recov
caveat sustain chines us consum growth engin
margin still expect rise free cash gener improv estim
momentum remain posit lot support move
note thinner outer line one standard deviat
bond yield remain eleph room limit neg yield risk-fre
asset discount valu futur cash flow remain inflat histor standard
linger fear own consum stapl stock rotat sharp
derat back histor norm fear own prove
repris past decad sclerot quixot polit backdrop ensur
import note see regulatori disclosur page report
sector derat bottom end five-year rang also
top end normal rang past year would equat downsid
derat fall averag leav valuat
establish portfolio posit across sector make
explicit call bond yield yield remain rang price-to-earnings
support howev bias compani protect
derat valuat one factor growth
compani trade five- averag fig
distil carlsberg offer greatest downsid averag
end scale tobacco compani trade near low
howev imperi brand profit warn highlight even level valuat
forward price-to-earnings versu high low averag year averag
note ccep price-to-earnings sinc european list ccep us list distort north american busi cchbc sinc
start due compani loss make prior
long-term sharehold compound earn offer reassur
event derat back averag averag ep growth
pa sector would take four year recov loss multipl
hold appreci mani investor luxuri four year
compound reliabl draw long-term sharehold sector
basi sever compani offer below-averag valuat
above-averag earn growth britvic heineken european
partner bat offer below-averag earn growth undemand multipl
imperi low valuat justifi prospect low earn growth
estim reckitt benckis price much higher growth forecast
offer limit protect despit discount peer group fig
import note see regulatori disclosur page report
fig look valuat growth
use redburn idea system look rel estim momentum
consum stapl sector coverag fig out-performance sector
sinc buoy persist low rate sinc also posit
rel ep estim momentum momentum remain posit octob
fade loom hold posit rel momentum
critic sector hold current rate
fig out-performance support posit rel momentum
redburn idea rel global univers
stock level carlsberg bat beiersdorf tate lyle top quartil
improv momentum versu three-month averag fig diageo
cchbc also top quartil seen momentum turn end
molson coor ag barr hover cusp bottom quartil stabl
improv long list compani momentum turn
still averag abinbev heineken campari imperi reckitt unilev
import note see regulatori disclosur page report
hover median line round consensu downgrad fever-tre
seen momentum improv low given consensu
ep year three see risk improv revers
fig broad spread earn momentum
note estim momentum rel idea global univers rank centil vertic line rang
histor data comprehens price-to-earnings basi compar compani
oper sale growth margin focu report
prefer look ev/ebit industri brew soft-drink bottl
much capital-intens distil beauti therefor differ
depreci level distort use ev/ebitda
also diverg capit structur beiersdorf net
cash compar abinbev net debt well broad spread tax
rate distort price-to-earnings multipl peer group trade forward ev/ebit back
near peak level fig
discuss earlier use core measur ebit includ restructur cost
compar compani diageo longer treat charg
import note see regulatori disclosur page report
except plot ev/ebit estim sustain long-
term post-curr ebit growth fig use uk consum stock prism
regard diageo assum crown consum bellweth fairli
valu sustain ebit growth pa core measur ev/ebit
unilev reckitt benckis fever-tre look overvalu rel long-term
sustain ebit growth bat britvic offer attract upsid
fig valu compound growth
sustain oper profit growth factor consid valuat
model brown-forman loral beiersdorf fever-tre make much higher
averag return turn command higher ev/ebit multipl
compar level growth capit requir gener sale oper
profit growth import input especi consid differ
capit characterist sector distil low capital-expenditure sale
compar brewer food compani capit tie age stock
stapl peer group seen return invest capit stabl rang
sinc fig underli improv led oper margin expans
better asset turn dilut period consolid aggreg
invest capit increas
import note see regulatori disclosur page report
fig return subdu capit expans
consum stapl wacc invest capit us trn
compani discount expans return ev/ic
multipl ahead roic/wacc except tobacco compani molson
coor fig forecast greater declin return molson coor
next ten year price discount therebi reduc attract
low valuat tobacco compani model expand return
bat faster albeit lower base post reynold acquisit
note fever-tre includ chart ev/ic roic/wacc
back old rule
set target price use ten-year discount cash model
mind sensit output rang assumpt reflect
realiti share price explicitli model compani ten year countri region
categori regard worthwhil distinguish short-term
import note see regulatori disclosur page report
effect regulatori environment polit social cyclic company-specif
disrupt compani long-term structur growth potenti
standard valuat framework base around ten-year explicit model
look sustain level real organ sale growth adjust local
inflat currenc assess growth core oper margin
captur potenti grow sale less restructur final assess level
capit requir deliv growth
detail financi estim end report along chang
earn forecast sale growth big thing
consum stapl analyst compound effect mean look year three
forecast ass deviat consensu signific differ
due on-going adjust local inflat currenc gener
bearish stanc margin consensu coverag
note abinbev molson coor fever-tre imperi henkel reckitt
benckis ebit ep forecast posit
side ahead pernod ricard ccep beiersdorf fig
fig differ
follow updat model valuat framework made chang
recommend across coverag
reckitt benckis downgrad sell neutral
reckitt benckis portfolio brand across consum health infant nutrit
home care growth potenti momentum stall sinc
beset seri one-off event balanc industry-lead sale growth
profit mani year work point margin reset necessari
consensu alreadi model drop oper margin
regard half-way hous assum increment invest spread
across three divis oper margin contract
import note see regulatori disclosur page report
still attract stapl standard leav us consensu
dramat action would give us greater confid reckitt benckis
make way back sale growth rang pa line peer
group model margin reset compani maintain
guidanc stabl margin would impli upgrad oper
profit forecast consensu howev unless clear evid
sustain sale recoveri end full year would consid take
medium-term sale growth estim would advers impact
share trade ev/ebit price-to-earnings premium
discount stapl peer group respect target price
base ten-year dcf model assum wacc post-
currenc sale growth termin ebit margin long-term
growth pa equat forward ev/ebit price-to-earnings
dividend yield offer total sharehold return
downgrad sell neutral
reckitt benckis settl us depart justic resolv
potenti liabil relat indivior/suboxon existenti risk abat
valu break-up legal separ hygien make
spin-off sale either easier assum control premium hygien
busi ev/ebit would leav busi
line fair valu group therebi limit upsid growth
restor sustain
unilev downgrad sell neutral
expect less dramat action unilev growth slow still within
compani long-term rang pa compani impress sale
distribut network across emerg market lead portfolio brand
compani also pioneer purpose-l brand digit still
ambit reach oper margin target
emerg market footprint compani benefit higher sales-
weight inflat organ perform mani peer
estim volum price averag pa support
averag organ sale growth pa howev sales-weight inflat averag
pa period impli limit real growth price lag inflat
sale alon creat headwind surpris
unilev need constantli restructur mitig pressur free
resourc invest
import note see regulatori disclosur page report
expect invest beauti person divis order catch
market growth rate group oper margin reach
remain stabl thereaft leav us consensu
underli oper profit debat us core oper profit
given compani expect need save year
perpetu prior current effici programm on-going restructur cost
sale pa assum remain elev sale
fall back pa thereaft
core post-restructur basi share trade ev/ebit
price-to-earnings premium respect stapl peer group record
fall underli pre-restructur basi measur
unilev trade unjustifi ev/ebit premium peer given forecast
sustain post-curr ebit growth pa organ sale growth off-set
advers currenc movement limit margin expans
target price base ten-year dcf
model assum wacc pa post currenc sale growth termin
core oper margin long-term growth pa
equat ev/ebit price-to-earnings dividend yield offer total
sharehold return downgrad sell neutral
molson coor downgrad sell neutral
molson coor beer sell discount greater market
us canada europ inconsist execut portfolio lack mass
premium brand leav compani perenni share donor us pace
expect continu busi manag cash rather invest
growth increas margin pressur due persist volum de-lever
assum gradual sustain declin oper profit
share trade ev/ebit price-to-earnings discount respect
peer group show valu list argu discount
justifi given continu sale declin margin pressur medium term
equiti free cash yield may look compel come finit
declin cash tax benefit millercoor transact
target price base ten-year dcf model
oper margin long-term growth pa equat
ev/ebit price-to-earnings dividend yield offer total sharehold
return downgrad sell neutral
note recent innocu file tweak element chang
control programm sever week announc new ceo
alway sceptic see either coor molson famili seller
import note see regulatori disclosur page report
howev per recent call molson coor need consid option
take maxim futur potenti busi greatest risk
sell invest case molson coor could next famili exit
beiersdorf upgrad buy neutral
beiersdorf may suffer margin reset start year brand
portfolio well posit categori good innov respond
well invest sale distribut market digit well push
new geographi reset give us confid compani sustain organ
sale growth upper half medium-term rang pa consum
come lower margin base ineffici oper
work capit help fund invest attract natur oper
leverag support margin expans middl
compani target reset base still leav
beiersdorf consum margin peer group averag make oper
ev/ebit share trade line peer group despit offer
sustain post-curr ebit growth well ahead pa price-to-earnings
premium reflect cash balanc sheet judici acquisit
build scale import market recent acquisit copperton
us add extra leg invest case increas balanc sheet effici
underscor compani long-term growth potenti
target price base ten-year dcf model
assum wacc pa post currenc sale growth termin core
oper margin long-term growth pa equat
ev/ebit price-to-earnings dividend yield offer total sharehold
return upgrad buy neutral
balanc develop emerg market allow bat maintain
stabl absolut address market nicotin user despit overal continu lower
incid rate smoke manag declin volum continu
comfort off-set inflationari price
cultur transit new ceo bowl posit bat particip
effect shift nicotin consumpt away combust recent
announc restructur elimin posit compani
free fund invest behind next-gener product also re-
align compani adapt agil rapidli chang sector design
technolog triumph scale addict alon
import note see regulatori disclosur page report
restructur plan growth global platform also enabl
bat lower debt secur return fund sharehold attract
yield forecast slightli consensu howev current valuat
excess price existenti risk fundament analysi bat
bat trade ev/ebit price-to-earnings discount peer
group respect reflect market renew existenti concern
tobacco gener target price base ten-year dcf
model assum wacc pa post currenc sale growth
termin core oper margin long-term declin pa
equat ev/ebit price-to-earnings dividend yield offer total
sharehold return launch coverag buy recommend
recommend note brown-forman downgrad neutral
buy base valuat imperi brand launch neutral
rate valuat discount justifi risk margin reset new
ceo reinvigor compani next-gener strategi
chang estim
main chang estim brewer hpc compani
upgrad short-term estim molson coor due
improv market estim us beer market help boom hard
seltzer taken medium-term growth rate reflect increasingli
structur share loss upgrad carlsberg ep follow
encourag capit market day heineken rais forecast
long-term sale growth come short-term cost higher invest
lead ep downgrad
downgrad ep estim reckitt benckis reflect
reset profit elsewher hpc upgrad beiersdorf
show posit outlook potenti consum divis
back step-up invest downgrad estim henkel
reflect continu soft adhes second half weaker
underli perform beauti compound on-going advers impact
destock full year
forecast distil soft drink food compani left larg
unchang save updat currenc
import note see regulatori disclosur page report
fig chang ep estim
import note see regulatori disclosur page report
import note see regulatori disclosur page report
fig abinbev financi valuat
profit tax
balanc sheet
import note see regulatori disclosur page report
fig carlsberg financi valuat
profit tax
balanc sheet
import note see regulatori disclosur page report
